An increasing population of women of childbearing age have underlying congenital or acquired cardiovascular disease (CVD) in the US.1,2 For instance, among women aged 20 to 29 years, the prevalence of CVD (eg, coronary heart disease, heart failure, stroke, and hypertension) is estimated at 11.5%.3 The reasons for this include improved pediatric cardiac surgical care, which has enabled more than 90% of children with congenital heart disease to survive to adulthood, and increasing rates of cardiovascular (CV) risk factors among young women (eg, obesity, hypertension, and diabetes).2
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author: Stephanie B. Teal, MD, MPH, Department of Obstetrics and Gynecology and Reproductive Biology, University Hospitals Cleveland Medical Center, 11100 Euclid St, MAC-5034, Cleveland, OH 44106 (firstname.lastname@example.org).
Published Online: July 22, 2022. doi:10.1001/jama.2022.11541
Conflict of Interest Disclosures: Dr Teal reported honoraria from Merck & Co (data and safety monitoring board) and Bayer Healthcare (scientific advisory board); and grants to her institution while serving as principal investigator from Merck & Co, Bayer Healthcare, Sebela, Medicines 360, and Chemo Research outside the submitted work. No other disclosures were reported.
You currently have no searches saved.
You currently have no courses saved.